Last update:

Oncology news

Blocking a cellular inflammation process could result in effective therapy for pancreatic cancer

Scientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could be targeted as a potential ...

Experimental KRAS G12D drug slows cancer growth, shrinks tumors in early test

A first-in-human clinical trial led by an international team of researchers and published in the New England Journal of Medicine found that setidegrasib, an investigational targeted therapy drug designed to eliminate a key ...

Dietary fats shape pancreatic cancer risk via ferroptosis

For decades, the relationship between fat and cancer has been treated as a question of quantity: Eat less fat, reduce your risk of developing cancer. But new research published April 29 in Cancer Discovery shows that for ...